d-alpha tocopherol has been researched along with clofibrate in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (65.00) | 18.7374 |
| 1990's | 4 (20.00) | 18.2507 |
| 2000's | 1 (5.00) | 29.6817 |
| 2010's | 2 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aizawa, Y; Fujita, T; Hasegawa, K; Horikoshi, H; Kanai, T; Kurumada, T; Yoshioka, T | 1 |
| Strassburg, CP; Tukey, RH | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Leonhardt, ET | 1 |
| Gniwotta, E; Herter, B | 1 |
| Mustard, JF; Packham, MA | 1 |
| Boberg, J; Lithell, H; Vessby, B | 1 |
| Fosbrooke, AS; Lloyd, JK; West, RJ | 1 |
| Beaty, MM; Borges, T; Chen, LC; Chow, CK; Clark, TD; Clark, TL; Glauert, HP; Greenwell, WS; Srinivasan, SR; Tatum, V | 1 |
| Chow, CK; Glauert, HP; Srinivasan, SR | 1 |
| Antonenkov, VD; Panchenko, LF; Pirozhkov, SV; Popova, SV | 1 |
| Corrigan, JJ; Marcus, FI | 1 |
| Besançon, F; Marche, C | 1 |
| Chiou, WL; Smith, LD | 1 |
| Oehme, FW; Onyeama, HP | 1 |
| Kibata, M; Takano, T; Tsurute, S | 1 |
| Appelkvist, EL; Cai, Y; DePierre, JW | 1 |
| Billiar, TR; Clarke, MR; Isaacson, IA; Paul, HS; Sekas, G; Stanko, RT | 1 |
5 review(s) available for d-alpha tocopherol and clofibrate
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Clinical pharmacology of platelets.
Topics: Adenosine Diphosphate; Aspirin; Blood Coagulation; Blood Platelets; Cell Membrane; Clofibrate; Cyproheptadine; Dipyridamole; Drug Therapy, Combination; Furosemide; Halofenate; Heparin; Humans; Hydrocortisone; Hydroxychloroquine; Methylprednisolone; Penicillin G; Platelet Aggregation; Propranolol; Prostaglandins; Sulfinpyrazone; Vitamin E | 1977 |
Hypervitaminosis E and coagulation.
Topics: Animals; Blood Coagulation Disorders; Blood Coagulation Factors; Clofibrate; Ecchymosis; Humans; Male; Middle Aged; Prothrombin Time; Vitamin E; Vitamin K; Warfarin | 1975 |
A literature review of paraquat toxicity.
Topics: Acetylcysteine; Animals; Butylated Hydroxytoluene; Clofibrate; Collagen; Diquat; Drug Synergism; Humans; Niacin; Oxygen; Paraquat; Pulmonary Fibrosis; Rats; Superoxide Dismutase; Vitamin E | 1984 |
2 trial(s) available for d-alpha tocopherol and clofibrate
| Article | Year |
|---|---|
Effect of vitamin E on serum cholesterol and triglycerides in hyperlipidemic patients treated with diet and clofibrate.
Topics: Adult; Aged; Cholesterol; Clinical Trials as Topic; Clofibrate; Fatty Acids, Unsaturated; Female; Humans; Hyperlipidemias; Lipids; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Middle Aged; Placebos; Triglycerides; Vitamin E | 1978 |
[Lipid-lowering effect of a combination of clofibrate and DL-alpha-tocopherol nicotinate in unselected hyperlipemic patients].
Topics: Adult; Aged; Clinical Trials as Topic; Clofibrate; Drug Combinations; Female; Humans; Hyperlipidemias; Male; Middle Aged; Nicotinic Acids; Vitamin E | 1977 |
13 other study(ies) available for d-alpha tocopherol and clofibrate
| Article | Year |
|---|---|
Studies on hindered phenols and analogues. 1. Hypolipidemic and hypoglycemic agents with ability to inhibit lipid peroxidation.
Topics: Animals; Hypoglycemic Agents; Hypolipidemic Agents; Lipid Peroxidation; Male; Mice; Mice, Inbred BALB C; Phenols; Rats; Structure-Activity Relationship | 1989 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Supplementation with vitamin E in hyperlipidemic patients treated with diet and clofibrate. Effects on serum lipoprotein concentrations, plasma fatty acid composition and adipose tissue lipoprotein lipase activity.
Topics: Adipose Tissue; Aged; Cholesterol Esters; Clofibrate; Fatty Acids; Fatty Acids, Unsaturated; Female; Humans; Hyperlipidemias; Lipids; Lipoprotein Lipase; Lipoproteins; Male; Middle Aged; Phospholipids; Triglycerides; Vitamin E | 1977 |
Treatment of children with familial hypercholesterolaemia.
Topics: Adolescent; Celiac Disease; Child; Child, Preschool; Cholestyramine Resin; Clofibrate; Fatty Acids, Unsaturated; Female; Folic Acid Deficiency; Follow-Up Studies; Heterozygote; Humans; Hypercholesterolemia; Infant; Male; Phosphorus; Vitamin A; Vitamin E | 1975 |
Effect of dietary vitamin E on the development of altered hepatic foci and hepatic tumors induced by the peroxisome proliferator ciprofibrate.
Topics: Adenosine Triphosphatases; Animals; Clofibrate; Clofibric Acid; Drug Synergism; Female; Fibric Acids; gamma-Glutamyltransferase; Glucose-6-Phosphatase; Liver; Liver Neoplasms, Experimental; Rats; Rats, Inbred Strains; Vitamin E | 1990 |
Effect of the peroxisome proliferator ciprofibrate on hepatic DNA synthesis and hepatic composition following partial hepatectomy in rats.
Topics: Administration, Oral; Animals; Body Weight; Clofibrate; Clofibric Acid; DNA; Female; Fibric Acids; Hepatectomy; Hypolipidemic Agents; Liver; Organ Size; Rats; Rats, Inbred Strains; Vitamin E | 1990 |
Effect of chronic ethanol, catalase inhibitor 3-amino-1,2,4-triazole and clofibrate treatment on lipid peroxidation in rat myocardium.
Topics: Amitrole; Animals; Catalase; Clofibrate; Drug Interactions; Ethanol; Heart; Lipid Peroxidation; Luminescent Measurements; Male; Myocardium; Rats; Rats, Inbred Strains; Time Factors; Triazoles; Vitamin E | 1989 |
Coagulopathy associated with vitamin E ingestion.
Topics: Blood Coagulation Disorders; Blood Coagulation Factors; Blood Coagulation Tests; Clofibrate; Hemorrhage; Humans; Male; Methods; Middle Aged; Prothrombin Time; Pulmonary Embolism; Sodium; Vitamin E; Vitamin K; Vitamin K Deficiency; Warfarin | 1974 |
[Pathologic and therapeutic similarities between arteriosclerosis and lithiasic cholecystitis].
Topics: Acetamides; Aminosalicylic Acids; Animals; Arteriosclerosis; Aspirin; Cholecystitis; Cholelithiasis; Cholesterol; Cholestyramine Resin; Clofibrate; Diagnosis, Differential; Humans; Lipids; Mice; Thyroxine; Vitamin E | 1971 |
Solid dispersion approach to the formulation of organic liquid drugs using polyethylene glycol 6000 as a carrier.
Topics: Benzoates; Clofibrate; Delayed-Action Preparations; Drug Compounding; Glycols; Methods; Polyethylenes; Salicylates; Solubility; Time Factors; Vitamin E | 1971 |
Tocofibrate (tocopheryl 2-(p-chlorophenoxy) isobutyrate); a new peroxisomotropic compound, and its hypocholesterolemic activity in cholesterol-fed rats.
Topics: Animals; Anticholesteremic Agents; Cholesterol; Clofibrate; Liver; Male; Microbodies; Organoids; Phenylpropionates; Rats; Rats, Inbred Strains; Vitamin E | 1982 |
Hepatic oxidative stress and related defenses during treatment of mice with acetylsalicylic acid and other peroxisome proliferators.
Topics: Acyl Coenzyme A; Amitrole; Animals; Aspirin; Caprylates; Catalase; Clofibrate; Decanoic Acids; Diet; Fluorocarbons; Glutathione Peroxidase; Glutathione Reductase; Glutathione Transferase; Lipid Peroxidation; Liver; Mice; Mice, Inbred C57BL; Microbodies; Microsomes, Liver; Mitochondria, Liver; NAD(P)H Dehydrogenase (Quinone); Nafenopin; Oxidation-Reduction; Oxidative Stress; Palmitoyl Coenzyme A; Superoxide Dismutase; Ubiquinone; Vitamin E | 1995 |
Pyruvate inhibits clofibrate-induced hepatic peroxisomal proliferation and free radical production in rats.
Topics: Animals; Body Weight; Catalase; Clofibrate; Diet; Drug Interactions; Free Radicals; Lipofuscin; Liver; Male; Microbodies; Microscopy, Electron; Organ Size; Oxidation-Reduction; Pyruvates; Pyruvic Acid; Rats; Rats, Sprague-Dawley; Vitamin E | 1995 |